Press Resease

Hematology Analyzers and Reagents Market - Global Industry Analysis

Hematology Analyzers and Reagents Market by Product (Instruments [Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Coagulation Analyzers and Other Analyzers], Reagents and Consumables, and Services), by Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Others), and by End-User (Hospitals, Commercial Service Providers, Reference Laboratories, and Research and Academic Institutes): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 11-Sep-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3324 Status : Published

Global hematology analyzers and reagents market expected to generate revenue of around USD 5.09 billion by end of 2024, growing at a CAGR of around 7.90% between 2018 and 2024. Rising innovation in the field of pharmacogenomics, genetic therapies, bleeding disorders, stem cell research, and proteomics driving the global market.

Description

The report covers forecast and analysis for the hematology analyzers and reagents market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hematology analyzers and reagents market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hematology analyzers and reagents market on a global level.

In order to give the users of this report a comprehensive view of the hematology analyzers and reagents market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product, application, end–user, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hematology Analyzers and Reagents Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the hematology analyzers and reagents market by segmenting the market based on product, application, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries.

Some of the leading players in hematology analyzers and reagents market include Abbott Diagnostics, Bio-Rad Laboratories, Drew Scientific, Sysmex Corporation, Siemens AG, Bayer Healthcare, Beckman Coulter, Heska Corporation, Danaher Corporation, and Cholestech Corporation.

This report segments the global hematology analyzers and reagents market as follows:

Global Hematology Analyzers and Reagents Market: Product Segment Analysis

  • Instruments
    • Hematology Analyzers
      • 5-Part and 6-Part Fully Automated Hematology Analyzers
      • 3-Part Fully Automated Hematology Analyzers
      • Semi-Automated Hematology Analyzers
      • Point-Of-Care Testing Hematology Analyzers
    • Hemostasis Analyzers
    • Plasma Protein Analyzers
    • Coagulation Analyzers
    • Other Analyzers
  • Reagents and Consumables
  • Services

Global Hematology Analyzers and Reagents Market: Application Segment Analysis

  • Anemia
  • Blood Cancer
  • Hemorrhagic Conditions
  • Infection-Related Conditions
  • Immune System Related Conditions
  • Others

Global Hematology Analyzers and Reagents Market: End-User Segment Analysis

  • Hospitals
  • Commercial Service Providers
  • Reference Laboratories
  • Research and Academic Institutes

Global Hematology Analyzers and Reagents Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global hematology analyzers and reagents market, 2017 - 2024 (USD Billion)
    • 2.2. Global hematology analyzers and reagents market : snapshot
  •  
  • Chapter 3. Hematology Analyzers and Reagents Market - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global hematology analyzers and reagents market drivers: impact analysis
      • 3.2.2. Rise in blood donations
      • 3.2.3. Increasing incidences of blood disorders
    • 3.3. Market Restraints
      • 3.3.1. Global hematology analyzers and reagents market restraints: impact analysis
      • 3.3.2. Product recalls and safety alerts
    • 3.4. Opportunities
      • 3.4.1. Emergence of microfluidics technology
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by application segment
      • 3.6.3. Market attractiveness analysis, by end user segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Hematology Analyzers and Reagents Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global hematology analyzers and reagents market : company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Hematology Analyzers and Reagents Market - Product Segment Analysis
    • 5.1. Global hematology analyzers and reagents market : product overview
      • 5.1.1. Global hematology analyzers and reagents market revenue share, by product, 2017 and 2024
    • 5.2. Instruments
      • 5.2.1. Global hematology analyzers and reagents market for instruments, 2017 - 2024 (USD Billion)
        • 5.2.1.1. Hematology Analyzers
          • 5.2.1.1.1. Global hematology analyzers market, 2017 - 2024 (USD Billion)
        • 5.2.1.2. Hemostasis Analyzers
          • 5.2.1.2.1. Global hemostasis analyzers market, 2017 - 2024 (USD Billion)
        • 5.2.1.3. Plasma Protein Analyzers
          • 5.2.1.3.1. Global plasma protein analyzers market, 2017 - 2024 (USD Billion)
        • 5.2.1.4. Coagulation Analyzers
          • 5.2.1.4.1. Global coagulation analyzers market, 2017 - 2024 (USD Billion)
        • 5.2.1.5. Other Analyzers
          • 5.2.1.5.1. Global other analyzers market, 2017 - 2024 (USD Billion)
    • 5.3. Reagents and Consumables
      • 5.3.1. Global hematology analyzers and reagents market for reagents and consumables, 2017 - 2024 (USD Billion)
    • 5.4. Services
      • 5.4.1. Global hematology analyzers and reagents market for services, 2017 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Hematology Analyzers and Reagents Market - Application Segment Analysis
    • 6.1. Global hematology analyzers and reagents market : application overview
      • 6.1.1. Global hematology analyzers and reagents market revenue share, by application, 2017 and 2024
    • 6.2. Anemia
      • 6.2.1. Global hematology analyzers and reagents market for anemia, 2017 - 2024 (USD Billion)
    • 6.3. Blood Cancer
      • 6.3.1. Global hematology analyzers and reagents market for blood cancer, 2017 - 2024 (USD Billion)
    • 6.4. Hemorrhagic Conditions
      • 6.4.1. Global hematology analyzers and reagents market for hemorrhagic conditions, 2017 - 2024 (USD Billion)
    • 6.5. Infection-Related Conditions
      • 6.5.1. Global hematology analyzers and reagents market for infection related conditions, 2017 - 2024 (USD Billion)
    • 6.6. Immune System Related Conditions
      • 6.6.1. Global hematology analyzers and reagents market for immune system related conditions, 2017 - 2024 (USD Billion)
    • 6.7. Others
      • 6.7.1. Global hematology analyzers and reagents market for others, 2017 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Hematology Analyzers and Reagents Market - End-User Segment Analysis
    • 7.1. Global hematology analyzers and reagents market: an end-user overview
      • 7.1.1. Global hematology analyzers and reagents market revenue share, by end user, 2017 and 2024
    • 7.2. Hospitals
      • 7.2.1. Global hematology analyzers and reagents market for hospitals, 2017 - 2024 (USD Billion)
    • 7.3. Commercial Service Providers
      • 7.3.1. Global hematology analyzers and reagents market for commercial service providers, 2017 - 2024 (USD Billion)
    • 7.4. Reference Laboratories
      • 7.4.1. Global hematology analyzers and reagents market for reference laboratories, 2017 - 2024 (USD Billion)
    • 7.5. Research and Academic Institutes
      • 7.5.1. Global hematology analyzers and reagents market for research and academic institutes, 2017 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Hematology Analyzers and Reagents Market - Regional Segment Analysis
    • 8.1. Global hematology analyzers and reagents market : regional overview
      • 8.1.1. Global hematology analyzers and reagents market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.2.2. North America hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
      • 8.2.3. North America hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.2.4.2. The U.S. hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.2.4.3. The U.S. hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.2.5. Canada
        • 8.2.5.1. Canada hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.2.5.2. Canada hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.2.5.3. Canada hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.3.2. Europe hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
      • 8.3.3. Europe hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.3.4.2. U.K. hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.3.4.3. U.K. hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.3.5.2. Germany hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.3.5.3. Germany hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.3.6.2. France hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.3.6.3. France hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.3.7.2. Rest of Europe hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.3.7.3. Rest of Europe hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.4.2. Asia Pacific hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
      • 8.4.3. Asia Pacific hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.4.4.2. China hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.4.4.3. China hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.4.5.2. Japan hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.4.5.3. Japan hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.4.6.2. India hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.4.6.3. India hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.5.2. Latin America hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
      • 8.5.3. Latin America hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.5.4.2. Brazil hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.5.4.3. Brazil hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.5.5.2. Rest of Latin America hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.5.5.3. Rest of Latin America hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.6.2. The Middle East and Africa hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
      • 8.6.3. The Middle East and Africa hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.6.4. Saudi Arabia
        • 8.6.4.1. Saudi Arabia hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.6.4.2. Saudi Arabia hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.6.4.3. Saudi Arabia hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.6.5. UAE
        • 8.6.5.1. UAE hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.6.5.2. UAE hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.6.5.3. UAE hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.6.6.2. South Africa hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.6.6.3. South Africa hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
      • 8.6.7. Rest of the Middle East and Africa
        • 8.6.7.1. Rest of the Middle East and Africa hematology analyzers and reagents market revenue, by product, 2017 - 2024 (USD Billion)
        • 8.6.7.2. Rest of the Middle East and Africa hematology analyzers and reagents market revenue, by application, 2017 - 2024 (USD Billion)
        • 8.6.7.3. Rest of the Middle East and Africa hematology analyzers and reagents market revenue, by end user, 2017 - 2024 (USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Abbott Diagnostics
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Bio-Rad Laboratories
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Drew Scientific
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Sysmex Corporation
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Siemens AG
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Bayer Healthcare
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Beckman Coulter
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Heska Corporation
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Danaher Corporation
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Cholestech Corporation
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

List of Figures 

1. Market research process
2. Market methodology
3. Global hematology analyzers and reagents market revenue, 2017 – 2024 (USD Billion) 
4. Porter’s five forces analysis
5. Hematology analyzers and reagents market attractiveness analysis, by product segment
6. Hematology analyzers and reagents market attractiveness analysis, by application segment
7. Hematology analyzers and reagents market attractiveness analysis, by end user segment
8. Hematology analyzers and reagents market attractiveness analysis, by regional segment
9. Company market share analysis, 2017 
10. Global hematology analyzers and reagents market revenue share by product, 2017 and 2024
11. Global hematology analyzers and reagents market for instruments, 2017 – 2024 (USD Billion)
12. Global hematology analyzers and reagents market for reagents, 2017 – 2024 (USD Billion)
13. Global hematology analyzers and reagents market for services, 2017 – 2024 (USD Billion)
14. Global hematology analyzers and reagents market revenue share by application, 2017 and 2024
15. Global hematology analyzers and reagents market for anemia and traumatology, 2017 – 2024 (USD Billion)
16. Global hematology analyzers and reagents market for blood cancer, 2017 – 2024 (USD Billion)
17. Global hematology analyzers and reagents market for hemorrhagic conditions, 2017 – 2024 (USD Billion)
18. Global hematology analyzers and reagents market for infection related conditions, 2017 – 2024 (USD Billion)
19. Global hematology analyzers and reagents market for immune system related conditions, 2017 – 2024 (USD Billion)
20. Global hematology analyzers and reagents market for others, 2017 – 2024 (USD Billion)
21. Global hematology analyzers and reagents market revenue share by end user, 2017 and 2024
22. Global hematology analyzers and reagents market for hospitals, 2017 – 2024 (USD Billion)
23. Global hematology analyzers and reagents market for commercial service provider, 2017 – 2024 (USD Billion)
24. Global hematology analyzers and reagents market for reference laboratories, 2017 – 2024 (USD Billion)
25. Global hematology analyzers and reagents market for research and academic institutes, 2017 – 2024 (USD Billion)
26. Global hematology analyzers and reagents market revenue share by regions, 2017 and 2024
27. North America hematology analyzers and reagents market, 2017 – 2024 (USD Billion)
28. Europe hematology analyzers and reagents market, 2017 – 2024 (USD Billion)
29. Asia Pacific hematology analyzers and reagents market, 2017 – 2024 (USD Billion)
30. Latin America hematology analyzers and reagents market, 2017 – 2024 (USD Billion)
31. The Middle East and Africa hematology analyzers and reagents market, 2017 – 2024 (USD Billion)


List of Tables

1. Hematology analyzers and reagents market: market snapshot                                                                                                   
2. Drivers of global hematology analyzers and reagents market : impact analysis 
3. Restraints of global hematology analyzers and reagents market : impact analysis  
4. North America hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
5. North America hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
6. North America hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
7. The U.S. hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
8. The U.S. hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
9. The U.S. hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
10. Canada hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
11. Canada hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
12. Canada hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
13. Europe hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
14. Europe hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
15. Europe hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
16. U.K. hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
17. U.K. hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
18. U.K. hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
19. Germany hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
20. Germany hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
21. Germany hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
22. France hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
23. France hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
24. France hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
25. Rest of Europe hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion) 
26. Rest of Europe hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
27. Rest of Europe hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
28. Asia Pacific hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
29. Asia Pacific hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
30. Asia Pacific hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
31. China hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
32. China hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
33. China hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
34. Japan hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
35. Japan hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
36. Japan hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
37. India hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
38. India hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
39. India hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
40. Rest of Asia Pacific hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
41. Rest of Asia Pacific hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
42. Rest of Asia Pacific hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
43. Latin America hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
44. Latin America hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
45. Latin America hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
46. Brazil hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
47. Brazil hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
48. Brazil hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
49. Rest of Latin America hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
50. Rest of Latin America hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
51. Rest of Latin America hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
52. The Middle East and Africa hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
53. The Middle East and Africa hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
54. The Middle East and Africa hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
55. Saudi Arabia hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
56. Saudi Arabia hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
57. Saudi Arabia hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
58. UAE hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
59. UAE hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
60. UAE hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
61. South Africa hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
62. South Africa hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
63. South Africa hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)
64. Rest of the Middle East and Africa hematology analyzers and reagents market revenue, by product, 2017 – 2024 (USD Billion)
65. Rest of the Middle East and Africa hematology analyzers and reagents market revenue, by application, 2017 – 2024 (USD Billion)
66. Rest of the Middle East and Africa hematology analyzers and reagents market revenue, by end user, 2017 – 2024 (USD Billion)

Methodology

Free Analysis

Hematology is a branch of science which deals with the study of disorders related to blood. It also deals with the liquid portion of blood called plasma. Whereas, hematology analyzers are highly specialized instruments which are used to count the number of platelets, red blood cells, and white blood cells. These analyzers are made up of multiple analytical modules which have a unique sample preparation process. These instruments assist in the diagnosis of multiple diseases like anemia, infections, genetic problems, viruses, cancer, and diabetes. The complexity of the instrument varies with the level of automation, type of test, and as per the requirement of computer connectivity.

Recently, new developments like VCS i.e. volume, conductivity, and scatter technology many new types of automated hematology analyzers and reagents are introduced in the market. The integration of modern hematology analyzers and flow-cytometry, rising adoption rate, and automation of analyzers due to technological advancements are some of the key factors driving the growth of hematology analyzers and reagents market over the forecast period. Moreover, the emerging economies are rapidly adopting the automated hematology analyzers, which have further increased the demand for hematology analyzers in the market. However, factors such as stringent regulatory environment and high initial cost of instrument setup are hindering the hematology analyzers and reagents market growth.

Global Hematology Analyzers and Reagents Market

The market for hematology analyzers and reagents is segmented based on product type, application type, and by end-user. Based on product type, the market is segmented into instruments, reagents and consumables, and services. The instruments segment is further divided into hematology analyzers, hemostasis analyzers, plasma protein analyzers, coagulation analyzers, and other analyzers. The hematology analyzers are further fragmented into point-of-care testing hematology analyzers, 3-part fully automated hematology analyzers, 5-part and 6-part fully automated hematology analyzers, and semi-automated hematology analyzers. Based on applications, the market is segmented into anemia, blood cancer, hemorrhagic conditions, infection-related conditions, conditions related to the immune system, and others. The end-user segment is divided into commercial service providers, hospitals, reference laboratories, and research and academic institutes.

North America held the largest share in the hematology analyzers and reagents market followed by Europe. The growth in these two regions is mainly attributed to the rising adoption of automated hematology instruments by most of the laboratories and high disposable income of the population in these regions. However, the Asia Pacific is also anticipated to be the fastest growing market in the forecast period owing to the rising government funding for the development of hematology products and the developing healthcare infrastructure in this region. Also, large patient population base and rising awareness about better healthcare are also driving the market growth of hematology analyzers & reagents in the Asia Pacific.

Some of the leading players in hematology analyzers and reagents market include Abbott Diagnostics, Bio-Rad Laboratories, Drew Scientific, Sysmex Corporation, Siemens AG, Bayer Healthcare, Beckman Coulter, Heska Corporation, Danaher Corporation, and Cholestech Corporation.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social